世界のインテグリンアルファ4市場予測2021-2027:TE-5232、ATL-1102、カロテグラスト、ET-3764、その他

Market Monitor Globalが発行した調査報告書(MMG21DC17740)
◆英語タイトル:Integrin Alpha 4 Market - Global Outlook and Forecast 2021-2027
◆商品コード:MMG21DC17740
◆発行会社(リサーチ会社):Market Monitor Global
◆発行日:2021年12月
◆ページ数:107
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥455,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥591,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarket Monitor Global社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。

Market Monitor Global社が発行した本調査レポートは、世界のインテグリンアルファ4市場について調査し取りまとめました。インテグリンアルファ4の世界市場規模(2016年-2027年)、市場予測、企業別市場シェア、種類別分析(TE-5232、ATL-1102、カロテグラスト、ET-3764、その他)、用途別分析(急性虚血性脳卒中、セリアック病、てんかん、黒色腫、多発性硬化症、その他)、地域別分析(北米、アメリカ、カナダ、メキシコ、ヨーロッパ、ドイツ、フランス、イギリス、アジア、中国、日本、韓国、東南アジア、インド、南米、ブラジル、中東、アフリカなど)、関連メーカーの概要、市場動向・機会・成長・阻害要因、サプライチェーンなどの情報をお届けいたします。
・世界のインテグリンアルファ4市場規模2021年vs2027年
・世界のインテグリンアルファ4市場:売上予測2016年-2027年
・主要企業別のインテグリンアルファ4売上・市場シェア・価格
・インテグリンアルファ4の種類別市場規模:TE-5232、ATL-1102、カロテグラスト、ET-3764、その他
・インテグリンアルファ4の用途別市場規模:急性虚血性脳卒中、セリアック病、てんかん、黒色腫、多発性硬化症、その他
・地域別市場規模
・インテグリンアルファ4の北米市場:アメリカ市場、カナダ市場、メキシコ市場
・インテグリンアルファ4のヨーロッパ市場:ドイツ市場、フランス市場、イギリス市場など
・インテグリンアルファ4のアジア市場:中国市場、日本市場、韓国市場、東南アジア市場など
・インテグリンアルファ4の南米市場:ブラジル市場、アルゼンチン市場など
・インテグリンアルファ4の中東・アフリカ市場:トルコ市場、サウジアラビア市場、UAE市場など
・主要メーカー及びブランド概要:Amgen Inc、Antisense Therapeutics Ltd、Biogen Inc、BioMAS Ltd、Daiichi Sankyo Co Ltd、EA Pharma Co Ltd、Immunwork Inc、Morphic Therapeutic Inc、Protagonist Therapeutics Inc、Takeda Pharmaceutical Co Ltd、Viriom Inc
・世界のインテグリンアルファ4の生産能力2016年-2027年
・市場動向・機会・成長・阻害要因分析
・インテグリンアルファ4のサプライチェーン分析
・調査の結論
【レポートの概要】

This report contains market size and forecasts of Integrin Alpha 4 in global, including the following market information:
Global Integrin Alpha 4 Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Integrin Alpha 4 Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Integrin Alpha 4 companies in 2020 (%)
The global Integrin Alpha 4 market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Integrin Alpha 4 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Integrin Alpha 4 Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, By Type, 2020 (%)
TE-5232
ATL-1102
Carotegrast
ET-3764
Others

Global Integrin Alpha 4 Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, By Application, 2020 (%)
Acute Ischemic Stroke
Celiac Disease
Epilepsy
Melanoma
Multiple Sclerosis
Other

Global Integrin Alpha 4 Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Integrin Alpha 4 Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Integrin Alpha 4 revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Integrin Alpha 4 revenues share in global market, 2020 (%)
Key companies Integrin Alpha 4 sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Integrin Alpha 4 sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Amgen Inc
Antisense Therapeutics Ltd
Biogen Inc
BioMAS Ltd
Daiichi Sankyo Co Ltd
EA Pharma Co Ltd
Immunwork Inc
Morphic Therapeutic Inc
Protagonist Therapeutics Inc
Takeda Pharmaceutical Co Ltd
Viriom Inc

【レポートの目次】

1 Introduction to Research & Analysis Reports
1.1 Integrin Alpha 4 Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Integrin Alpha 4 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Integrin Alpha 4 Overall Market Size
2.1 Global Integrin Alpha 4 Market Size: 2021 VS 2027
2.2 Global Integrin Alpha 4 Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Integrin Alpha 4 Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Integrin Alpha 4 Players in Global Market
3.2 Top Global Integrin Alpha 4 Companies Ranked by Revenue
3.3 Global Integrin Alpha 4 Revenue by Companies
3.4 Global Integrin Alpha 4 Sales by Companies
3.5 Global Integrin Alpha 4 Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Integrin Alpha 4 Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Integrin Alpha 4 Product Type
3.8 Tier 1, Tier 2 and Tier 3 Integrin Alpha 4 Players in Global Market
3.8.1 List of Global Tier 1 Integrin Alpha 4 Companies
3.8.2 List of Global Tier 2 and Tier 3 Integrin Alpha 4 Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Integrin Alpha 4 Market Size Markets, 2021 & 2027
4.1.2 TE-5232
4.1.3 ATL-1102
4.1.4 Carotegrast
4.1.5 ET-3764
4.1.6 Others
4.2 By Type – Global Integrin Alpha 4 Revenue & Forecasts
4.2.1 By Type – Global Integrin Alpha 4 Revenue, 2016-2021
4.2.2 By Type – Global Integrin Alpha 4 Revenue, 2022-2027
4.2.3 By Type – Global Integrin Alpha 4 Revenue Market Share, 2016-2027
4.3 By Type – Global Integrin Alpha 4 Sales & Forecasts
4.3.1 By Type – Global Integrin Alpha 4 Sales, 2016-2021
4.3.2 By Type – Global Integrin Alpha 4 Sales, 2022-2027
4.3.3 By Type – Global Integrin Alpha 4 Sales Market Share, 2016-2027
4.4 By Type – Global Integrin Alpha 4 Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Integrin Alpha 4 Market Size, 2021 & 2027
5.1.2 Acute Ischemic Stroke
5.1.3 Celiac Disease
5.1.4 Epilepsy
5.1.5 Melanoma
5.1.6 Multiple Sclerosis
5.1.7 Other
5.2 By Application – Global Integrin Alpha 4 Revenue & Forecasts
5.2.1 By Application – Global Integrin Alpha 4 Revenue, 2016-2021
5.2.2 By Application – Global Integrin Alpha 4 Revenue, 2022-2027
5.2.3 By Application – Global Integrin Alpha 4 Revenue Market Share, 2016-2027
5.3 By Application – Global Integrin Alpha 4 Sales & Forecasts
5.3.1 By Application – Global Integrin Alpha 4 Sales, 2016-2021
5.3.2 By Application – Global Integrin Alpha 4 Sales, 2022-2027
5.3.3 By Application – Global Integrin Alpha 4 Sales Market Share, 2016-2027
5.4 By Application – Global Integrin Alpha 4 Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region – Global Integrin Alpha 4 Market Size, 2021 & 2027
6.2 By Region – Global Integrin Alpha 4 Revenue & Forecasts
6.2.1 By Region – Global Integrin Alpha 4 Revenue, 2016-2021
6.2.2 By Region – Global Integrin Alpha 4 Revenue, 2022-2027
6.2.3 By Region – Global Integrin Alpha 4 Revenue Market Share, 2016-2027
6.3 By Region – Global Integrin Alpha 4 Sales & Forecasts
6.3.1 By Region – Global Integrin Alpha 4 Sales, 2016-2021
6.3.2 By Region – Global Integrin Alpha 4 Sales, 2022-2027
6.3.3 By Region – Global Integrin Alpha 4 Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country – North America Integrin Alpha 4 Revenue, 2016-2027
6.4.2 By Country – North America Integrin Alpha 4 Sales, 2016-2027
6.4.3 US Integrin Alpha 4 Market Size, 2016-2027
6.4.4 Canada Integrin Alpha 4 Market Size, 2016-2027
6.4.5 Mexico Integrin Alpha 4 Market Size, 2016-2027
6.5 Europe
6.5.1 By Country – Europe Integrin Alpha 4 Revenue, 2016-2027
6.5.2 By Country – Europe Integrin Alpha 4 Sales, 2016-2027
6.5.3 Germany Integrin Alpha 4 Market Size, 2016-2027
6.5.4 France Integrin Alpha 4 Market Size, 2016-2027
6.5.5 U.K. Integrin Alpha 4 Market Size, 2016-2027
6.5.6 Italy Integrin Alpha 4 Market Size, 2016-2027
6.5.7 Russia Integrin Alpha 4 Market Size, 2016-2027
6.5.8 Nordic Countries Integrin Alpha 4 Market Size, 2016-2027
6.5.9 Benelux Integrin Alpha 4 Market Size, 2016-2027
6.6 Asia
6.6.1 By Region – Asia Integrin Alpha 4 Revenue, 2016-2027
6.6.2 By Region – Asia Integrin Alpha 4 Sales, 2016-2027
6.6.3 China Integrin Alpha 4 Market Size, 2016-2027
6.6.4 Japan Integrin Alpha 4 Market Size, 2016-2027
6.6.5 South Korea Integrin Alpha 4 Market Size, 2016-2027
6.6.6 Southeast Asia Integrin Alpha 4 Market Size, 2016-2027
6.6.7 India Integrin Alpha 4 Market Size, 2016-2027
6.7 South America
6.7.1 By Country – South America Integrin Alpha 4 Revenue, 2016-2027
6.7.2 By Country – South America Integrin Alpha 4 Sales, 2016-2027
6.7.3 Brazil Integrin Alpha 4 Market Size, 2016-2027
6.7.4 Argentina Integrin Alpha 4 Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Integrin Alpha 4 Revenue, 2016-2027
6.8.2 By Country – Middle East & Africa Integrin Alpha 4 Sales, 2016-2027
6.8.3 Turkey Integrin Alpha 4 Market Size, 2016-2027
6.8.4 Israel Integrin Alpha 4 Market Size, 2016-2027
6.8.5 Saudi Arabia Integrin Alpha 4 Market Size, 2016-2027
6.8.6 UAE Integrin Alpha 4 Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Amgen Inc
7.1.1 Amgen Inc Corporate Summary
7.1.2 Amgen Inc Business Overview
7.1.3 Amgen Inc Integrin Alpha 4 Major Product Offerings
7.1.4 Amgen Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.1.5 Amgen Inc Key News
7.2 Antisense Therapeutics Ltd
7.2.1 Antisense Therapeutics Ltd Corporate Summary
7.2.2 Antisense Therapeutics Ltd Business Overview
7.2.3 Antisense Therapeutics Ltd Integrin Alpha 4 Major Product Offerings
7.2.4 Antisense Therapeutics Ltd Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.2.5 Antisense Therapeutics Ltd Key News
7.3 Biogen Inc
7.3.1 Biogen Inc Corporate Summary
7.3.2 Biogen Inc Business Overview
7.3.3 Biogen Inc Integrin Alpha 4 Major Product Offerings
7.3.4 Biogen Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.3.5 Biogen Inc Key News
7.4 BioMAS Ltd
7.4.1 BioMAS Ltd Corporate Summary
7.4.2 BioMAS Ltd Business Overview
7.4.3 BioMAS Ltd Integrin Alpha 4 Major Product Offerings
7.4.4 BioMAS Ltd Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.4.5 BioMAS Ltd Key News
7.5 Daiichi Sankyo Co Ltd
7.5.1 Daiichi Sankyo Co Ltd Corporate Summary
7.5.2 Daiichi Sankyo Co Ltd Business Overview
7.5.3 Daiichi Sankyo Co Ltd Integrin Alpha 4 Major Product Offerings
7.5.4 Daiichi Sankyo Co Ltd Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.5.5 Daiichi Sankyo Co Ltd Key News
7.6 EA Pharma Co Ltd
7.6.1 EA Pharma Co Ltd Corporate Summary
7.6.2 EA Pharma Co Ltd Business Overview
7.6.3 EA Pharma Co Ltd Integrin Alpha 4 Major Product Offerings
7.6.4 EA Pharma Co Ltd Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.6.5 EA Pharma Co Ltd Key News
7.7 Immunwork Inc
7.7.1 Immunwork Inc Corporate Summary
7.7.2 Immunwork Inc Business Overview
7.7.3 Immunwork Inc Integrin Alpha 4 Major Product Offerings
7.4.4 Immunwork Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.7.5 Immunwork Inc Key News
7.8 Morphic Therapeutic Inc
7.8.1 Morphic Therapeutic Inc Corporate Summary
7.8.2 Morphic Therapeutic Inc Business Overview
7.8.3 Morphic Therapeutic Inc Integrin Alpha 4 Major Product Offerings
7.8.4 Morphic Therapeutic Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.8.5 Morphic Therapeutic Inc Key News
7.9 Protagonist Therapeutics Inc
7.9.1 Protagonist Therapeutics Inc Corporate Summary
7.9.2 Protagonist Therapeutics Inc Business Overview
7.9.3 Protagonist Therapeutics Inc Integrin Alpha 4 Major Product Offerings
7.9.4 Protagonist Therapeutics Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.9.5 Protagonist Therapeutics Inc Key News
7.10 Takeda Pharmaceutical Co Ltd
7.10.1 Takeda Pharmaceutical Co Ltd Corporate Summary
7.10.2 Takeda Pharmaceutical Co Ltd Business Overview
7.10.3 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Major Product Offerings
7.10.4 Takeda Pharmaceutical Co Ltd Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.10.5 Takeda Pharmaceutical Co Ltd Key News
7.11 Viriom Inc
7.11.1 Viriom Inc Corporate Summary
7.11.2 Viriom Inc Integrin Alpha 4 Business Overview
7.11.3 Viriom Inc Integrin Alpha 4 Major Product Offerings
7.11.4 Viriom Inc Integrin Alpha 4 Sales and Revenue in Global (2016-2021)
7.11.5 Viriom Inc Key News
8 Global Integrin Alpha 4 Production Capacity, Analysis
8.1 Global Integrin Alpha 4 Production Capacity, 2016-2027
8.2 Integrin Alpha 4 Production Capacity of Key Manufacturers in Global Market
8.3 Global Integrin Alpha 4 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Integrin Alpha 4 Supply Chain Analysis
10.1 Integrin Alpha 4 Industry Value Chain
10.2 Integrin Alpha 4 Upstream Market
10.3 Integrin Alpha 4 Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Integrin Alpha 4 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

...

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のインテグリンアルファ4市場予測2021-2027:TE-5232、ATL-1102、カロテグラスト、ET-3764、その他(Integrin Alpha 4 Market - Global Outlook and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆